Date of Conference
August 1-5th, 2010
June 25, 2010
Last date to get special rates for the Grand Hyatt Hotel
Conference Rates Available From: 07/25/10 - 08/12/10
Conference Rates:
Single- $209
Double- $209
Triple - $209
Quad - $209
Email:Berhane Ghebrehiwet
Program Overview
Wednesday, August 5, 2010
7:00 am - 1:45pm
All oral presentations are 10 min, with 5 min for questions. Presenters must load their power-point presentations on the session file at least one day prior to presentation. Speaker services will be available on site.
| 7:00 - 8:00 AM | Breakfast | |
| 8:00 - 9:00 AM | POSTER SESSION - 5 (Click for Details) |
|
| Session: Target Therapies/Inhibitors | ||
| 9:00 AM | C5a regulates antigen uptake and processing in mDCs as a novel means to regulate adaptive immune responses in experimental allergic asthma Inken Schmudde, Yves Laumonnier and Jörg Köhl |
|
| 9:15 AM | Identification and characterisation of C5a-inhibiting biostable aptamers Identification and characterisation of C5a-inhibiting biostable aptamers |
|
| 9:30 AM | Complement C5 inhibition attenuates lung inflammation in H1N1 influenza Wynne Weston-Davies*, Bernhard Ryffel**, Mauro M Teixeira‡, Cristiana C Garcia‡, Remo C Russo‡, Luciana P Tavares‡; Miles Nunn‡‡ |
|
| 9:45 AM | C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice Erdenechimeg Shagdarsuren1, Kiril Bidzhekov1, Sebastian Mause1, Sakine Simsekyilmaz1, Thomas Polakowski2, Heiko Hawlisch2, Alma Zernecke1,3, Christian Weber1,4 |
|
| 10:00 AM | Targeted complement inhibition significantly ameliorates ischemia reperfusion induced isograft inflammation in a murine model of cardiac transplantation Carl Atkinson1, Song He1, Keely Morris1, Sarah Casey1, Martin Goddard2, Stephen Tomlinson |
|
| 10:15 AM | The terminal pathway of complement in hepatic ischemia/reperfusion injury and regeneration Keely Morris (a), Songqing He (a), Carl Atkinson (a), B. Paul Morgan (b), Stephen Tomlinson (a) |
|
| 10:30 AM | Mannose binding lectin as a target for neuroprotection |
|
| 10:45 AM | The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity Antonio M. Risitano1, Caterina Pascariello1, Carmine Selleri1, Luigi Del Vecchio1, Michela Sica2, Masha Fridkis-Hareli3, Istvan Mazsaroff3, Christopher J. Horvath3, and V. Michael Holers3 |
|
| 11:00 AM | BREAK | |
| 11:15 - 11:30 PM | Meeting Summary AWARD PRESENTATIONS |
John Atkinson |
| 12:00 PM | ICW 2012 PREVIEW | |
| 12:00 PM | Adjournment | Berhane Ghebrehiwet |
| 12:30 - 1:15 PM | LUNCH | |
| 1:30 PM | POST CONGRESS Meeting | |
| 1:45 PM | Complement Standardization and Exteral Quality Assessment | Gyorgy Fust |